The Science of Opioids: Evaluating New Therapies to Optimize Opioid Stewardship

January 20, 2021
Health-System Edition, January 2021, Volume 10, Issue 1

This activity is supported by an independent medical education grant from AcelRx Pharmaceuticals, Inc.

This activity is supported by an independent medical education grant from AcelRx Pharmaceuticals, Inc.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

• Analyze the physiochemical and pharmacokinetic properties of opioids and how they relate to utilization and safety

• Examine the clinical data, safety, and pharmacokinetic characteristics of new and emerging opioids

• Optimize the integration of new opioids into practice and the role of the pharmacist in opioid stewardship

FACULTY

Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP, FFSMB

Founder, Remitigate LLC and Pharmacist Consulting Services PLLC

Owner and Managing Editor, PainDr.com and Pain Blog

Adjunct Associate Professor, Western New England University College of Pharmacy

Adjunct Associate Professor of Pharmacy Practice & Pain Management, Albany College of Pharmacy & Health Sciences

Section Co-Editor, Pain Medicine (Opioids, Substance Abuse, and Addictions)

Co-Editor-At-Large, Practical Pain Management, Albany, New York

Jeffrey J. Bettinger, PharmD

Pain Management Clinical Pharmacist

Saratoga Hospital Medical Group, Saratoga Springs, New York

Jacqueline H. Cleary, PharmD, BCACP

Assistant Professor, Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: December 23, 2020

EXPIRATION DATE: January 15, 2022

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.